- Home
- BBT vs ZLAB Comparison
BBT vs ZLAB Comparison
Compare BBT & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBT
- ZLAB
- Stock Information
- Founded
- BBT 1846
- ZLAB 2013
- Country
- BBT United States
- ZLAB China
- Employees
- BBT N/A
- ZLAB N/A
- Industry
- BBT Banks
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- BBT Finance
- ZLAB Health Care
- Exchange
- BBT Nasdaq
- ZLAB Nasdaq
- Market Cap
- BBT 2.0B
- ZLAB 2.2B
- IPO Year
- BBT N/A
- ZLAB 2017
- Fundamental
- Price
- BBT $25.94
- ZLAB $19.88
- Analyst Decision
- BBT Buy
- ZLAB Buy
- Analyst Count
- BBT 2
- ZLAB 6
- Target Price
- BBT $33.00
- ZLAB $57.22
- AVG Volume (30 Days)
- BBT 1.1M
- ZLAB 931.8K
- Earning Date
- BBT 10-29-2025
- ZLAB 11-06-2025
- Dividend Yield
- BBT 1.25%
- ZLAB N/A
- EPS Growth
- BBT N/A
- ZLAB N/A
- EPS
- BBT 0.09
- ZLAB N/A
- Revenue
- BBT $318,120,000.00
- ZLAB $441,629,000.00
- Revenue This Year
- BBT $63.25
- ZLAB $40.71
- Revenue Next Year
- BBT $64.02
- ZLAB $50.42
- P/E Ratio
- BBT $272.57
- ZLAB N/A
- Revenue Growth
- BBT N/A
- ZLAB 24.14
- 52 Week Low
- BBT $22.27
- ZLAB $19.51
- 52 Week High
- BBT $30.50
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- BBT N/A
- ZLAB 18.64
- Support Level
- BBT N/A
- ZLAB $19.51
- Resistance Level
- BBT N/A
- ZLAB $20.29
- Average True Range (ATR)
- BBT 0.00
- ZLAB 0.76
- MACD
- BBT 0.00
- ZLAB 0.02
- Stochastic Oscillator
- BBT 0.00
- ZLAB 7.44
About BBT Beacon Financial Corporation Common stock
Beacon Financial Corp operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.